CDMO Archives

Home CDMO

Latest Posts

CDMO, KBI Biopharma, antibody development

How to select the right CDMO for innovative antibody development

Choosing the right Contract Development and Manufacturing Organization (CDMO) is a pivotal decision for biopharmaceutical companies embarking on innovative antibody development projects. With the industry's increasing demand for qualified multidisciplinary…

July 11, 2023 - 4 minutesmins - By External Contributor

News and Trends 11 Jan 2023

Five key trends shaping life sciences in 2023

By Kevin Wayer, president - government, education, infrastructure and life sciences industries, JLL, and Travis McCready, head of life sciences, industries Americas, JLL After an unprecedented period of growth during…

January 11, 2023 - 5 minutesmins - By External Contributor

CTDMO, biomanufacturing, Merck, infographic

Infographics by

28 Mar 2023

Infographic: Why choosing a client-centric CTDMO is critical when outsourcing biomanufacturing projects

In 2021, 28% of FDA approvals were granted to biologic drugs, showcasing the increasing demand for the biopharma industry to develop, manufacture and market biologic-based therapies. Biologic drugs include monoclonal…

March 28, 2023 - 2 minutesmins - By Maya Chergova

News and Trends 9 Feb 2023

Icosagen receives €18M loan for R&D and new facility

The Estonian biopharma company Icosagen AS has reached an €18 million financing agreement with the European Investment Bank (EIB) backed by the InvestEU program. The funds will strengthen the company’s…

February 9, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 8 Nov 2022

GHO Capital and Vistria Group to acquire CDMO Alcami

Global Healthcare Opportunities, (GHO Capital Partners LLP), and The Vistria Group, have entered into a definitive agreement to acquire a controlling interest in Alcami Corporation, a pharmaceutical contract development and…

November 8, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 26 Oct 2022

ABL and RD-Biotech to partner on cell and gene therapy manufacturing

French companies ABL and RD-Biotech have signed a strategic partnership to cover cell and gene therapy (C&GT) GMP manufacturing. ABL, is a contract development and manufacturing organization (CDMO) that specializes…

October 26, 2022 - 2 minutesmins - By Jim Cornall

Resources

Categories

The latest news on

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

Download Inpart’s latest report

Americas

Asia Pacific

Europe

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Company

Join Us

Subcribe to our newsletter

Learn more about Inpart, the leading platform for biopharma partnering